Treatment of phantom shocks: A case report.
Antidepressive Agents
/ therapeutic use
Anxiety Disorders
/ complications
Cocaine-Related Disorders
/ complications
Defibrillators, Implantable
/ psychology
Depressive Disorder, Major
/ complications
Humans
Male
Middle Aged
Mirtazapine
/ therapeutic use
Sleep Initiation and Maintenance Disorders
/ complications
anxiety
depression
implantable cardioverter-defibrillators
phantom shocks
post-traumatic stress disorder
shock
Journal
International journal of psychiatry in medicine
ISSN: 1541-3527
Titre abrégé: Int J Psychiatry Med
Pays: United States
ID NLM: 0365646
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
pubmed:
25
9
2018
medline:
23
8
2019
entrez:
25
9
2018
Statut:
ppublish
Résumé
Implantable cardioverter-defibrillators have become standard preventive treatment for patients with ventricular arrhythmias and other life-threatening cardiac conditions. The advantages and efficiency of the device are supported by multiple clinical trials and outcome studies, leading to its popularity among cardiologists. Implantation of the device is not without adverse outcomes. Implantable cardioverter-defibrillator placement has been found to lead to negative psychological and psychosocial sequelae such as apprehension to engage in physical activity, chronic anxiety, decreased physical and social functioning, a nagging fear of being shocked by the device, and the development of "phantom shocks." Defined as patient-reported shocks in the absence of evidence that the implantable cardioverter-defibrillator device has discharged, phantom shocks could impact the mental health of those affected. This article reviews the case of Mr. L, a 47-year-old man with ischemic cardiomyopathy who was seen by the psychiatry consultation team while under cardiologic care because he reported that his implantable cardioverter-defibrillator device had been shocking him despite no objective evidence after interrogating the device. A literature review of phantom shocks, their associated symptomatology, and psychological consequences are outlined and discussed.
Identifiants
pubmed: 30244622
doi: 10.1177/0091217418802153
doi:
Substances chimiques
Antidepressive Agents
0
Mirtazapine
A051Q2099Q
Types de publication
Case Reports
Journal Article
Langues
eng